Cognetivity Neurosciences Ltd.
CGNSF · OTC
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $20,751 | $33,062 | $33,509 | $8,798 |
| - Cash | $2,244 | $1,377 | $1,360 | $578 |
| + Debt | $1,291 | $1,295 | $314 | $307 |
| Enterprise Value | $19,798 | $32,980 | $32,463 | $8,527 |
| Revenue | $45 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2,130 | -$25 | -$11 | -$9 |
| % Margin | -4,694.9% | – | – | – |
| EBITDA | -$6,382 | -$13,012 | -$2,393 | -$2,596 |
| % Margin | -14,067.1% | – | – | – |
| Net Income | -$7,434 | -$13,127 | -$1,928 | -$2,645 |
| % Margin | -16,386.3% | – | – | – |
| EPS Diluted | -0.087 | -0.18 | -0.033 | -0.058 |
| % Growth | 51.4% | -447.1% | 43.3% | – |
| Operating Cash Flow | -$5,942 | -$3,215 | -$1,959 | -$1,857 |
| Capital Expenditures | -$70 | -$100 | -$50 | -$22 |
| Free Cash Flow | -$6,012 | -$3,315 | -$2,009 | -$1,878 |